Ultivue
Ultivue
Claim
Ultivue provides translational medicine researchers with multiplex biomarker assays for tissue phenotyping and digital pathology. Its proprietary InSituPlex technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions and scientific advisory approach strengthen and accelerate biomarker discovery and drug development programs.Ultivue provides translational medicine researchers with multiplex biomarker assays for tissue pheno Show More
Alpha Score
$ 100.77 M
Alpha Score
79.7
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0